Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 15/20 | 0.74 |
| ▸ | PTPN2 | P17706 | 5/20 | 0.74 |
| ▸ | PTPN6 | P29350 | 5/20 | 0.74 |
| ▸ | PTPN11 | Q06124 | 4/20 | 0.74 |
| ▸ | PGK1 | P00558 | 2/20 | 0.60 |
| ▸ | PGK2 | P07205 | 2/20 | 0.60 |
| ▸ | PTPRB | P23467 | 3/20 | 0.51 |
| ▸ | PTPRC | P08575 | 3/20 | 0.51 |
| ▸ | CDC25A | P30304 | 1/20 | 0.51 |
| ▸ | PTPN5 | P54829 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4316970 | 0.86 | PTPN1 (1.00) | PTPN1PTPN2PTPN6PTPN11PGK1 | |
| SCHEMBL5163594 | 0.84 | PGK1 (0.59) | PTPN1PTPN2PTPN6PTPN11PGK1 | |
| SCHEMBL7660739 | 0.84 | PGK1 (0.59) | PTPN1PTPN2PTPN6PTPN11PGK1 | |
| SCHEMBL7188019 | 0.83 | PGK1 (0.57) | PTPN1PTPN2PTPN6PTPN11PGK1 | |
| SCHEMBL7591720 | 0.83 | PGK1 (0.57) | PTPN1PTPN2PTPN6PTPN11PGK1 | |
| SCHEMBL5892025 | 0.82 | PGK1 (0.56) | PTPN1PTPN2PTPN6PTPN11PGK1 | |
| SCHEMBL5165050 | 0.80 | PGK1 (0.50) | PTPN1PTPN2PTPN6PTPN11PGK1 | |
| SCHEMBL5003956 | 0.79 | PTPN1 (0.67) | PTPN1PTPN2PTPN6PTPN11PGK1 | |
| SCHEMBL5163005 | 0.78 | PTPN5 (0.57) | PTPN1PTPN2PTPN6PTPN11PGK1 | |
| SCHEMBL7890197 | 0.78 | PGK1 (0.51) | PTPN1PTPN2PTPN6PTPN11PGK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11573224-B2 | Methods of detection using X-ray fluorescence | ICAGEN, LLC (US) | 2023-02-07 | — | — | US | disclosed |
| US-10877035-B2 | Advanced drug development and manufacturing | ICAGEN, LLC (US) | 2020-12-29 | — | — | US | disclosed |
| US-20200278346-A1 | METHODS OF DETECTION USING X-RAY FLUORESCENCE | ADJACENT ACQUISITION CO., LLC | 2020-09-03 | — | — | US | disclosed |
| US-20150309021-A1 | Advanced Drug Development and Manufacturing | LOS ALAMOS NATIONAL SECURITY, LLC | 2015-10-29 | — | — | US | disclosed |
| EP-2511844-B1 | X-ray microscope | XRPRO SCIENCES INC (US) | 2015-08-12 | — | — | EP | disclosed |
| EP-2084519-B1 | X-RAY FLUORESCENCE ANALYSIS METHOD | LOS ALAMOS NAT SECURITY LLC (US) | 2012-08-01 | — | — | EP | disclosed |
| EP-2084519-A2 | ADVANCED DRUG DEVELOPMENT AND MANUFACTURING | Los Alamos National Security, LLC (US) | 2009-08-05 | — | — | EP | disclosed |
| WO-2008127291-A2 | ADVANCED DRUG DEVELOPMENT AND MANUFACTURING | LOS ALAMOS NATIONAL SECURITY, LLC (US) | 2008-10-23 | — | — | WO | disclosed |
| US-20080220441-A1 | Advanced drug development and manufacturing | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2008-09-11 | — | — | US | disclosed |